These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Chemosensitivity studies on human tumour cells from a pancreatic carcinoma xenograft. Smith IE J R Soc Med; 1979 Apr; 72(4):260-3. PubMed ID: 552510 [No Abstract] [Full Text] [Related]
7. Use of the agar diffusion chamber for the exposure of human tumor cells to drugs. Selby PJ; Steel GG Cancer Res; 1982 Nov; 42(11):4758-62. PubMed ID: 7127312 [TBL] [Abstract][Full Text] [Related]
8. Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole. Stephens TC; Courtenay VD; Mills J; Peacock JH; Rose CM; Spooner D Br J Cancer; 1981 Apr; 43(4):451-7. PubMed ID: 7236488 [TBL] [Abstract][Full Text] [Related]
10. Characterisation and chemosensitivity of a well-differentiated murine transplantable adenocarcinoma of the colon. Double JA; Bibby MC Br J Cancer; 1983 Nov; 48(5):739-42. PubMed ID: 6639861 [No Abstract] [Full Text] [Related]
11. Recent developments in cancer chemotherapy. Winokur S J Med Assoc Ga; 1977 Sep; 66(9):729-30. PubMed ID: 143505 [No Abstract] [Full Text] [Related]
12. [Chemotherapy of prostatic cancer]. Portnoĭ AS Vopr Onkol; 1985; 31(9):3-12. PubMed ID: 2931901 [No Abstract] [Full Text] [Related]
13. Combination chemotherapy in isolation perfusion: use of mitotic inhibitors in pretreatment of V x 2 carcinoma undergoing isolation perfusion with alkylating agents. Mashima Y; Nagatsu M; Lambert A Cancer Chemother Rep; 1972 Apr; 56(2):175-81. PubMed ID: 5043225 [No Abstract] [Full Text] [Related]
14. Correlation between experimentally and clinically demonstrated activity of two new cytotoxic agents in breast cancer. Bailey MJ; Smith IE Anticancer Res; 1985; 5(4):419-22. PubMed ID: 3839994 [TBL] [Abstract][Full Text] [Related]
15. Characteristics and chemotherapeutic sensitivity of a human testicular cancer grown in artificially immunosuppressed mice. Lapis P; Kopper L; Bodrogi I; Sugár J; Lapis K; Eckhardt S Oncology; 1985; 42(2):112-8. PubMed ID: 2581199 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP). Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331 [TBL] [Abstract][Full Text] [Related]
17. Growth and chemotherapy of a human germ-cell tumour line (GCT 27). Schlappack OK; Bush C; Delic JI; Steel GG Strahlenther Onkol; 1989 Jul; 165(7):541. PubMed ID: 2473535 [No Abstract] [Full Text] [Related]
18. New drugs under clinical evaluation in the United States. Carter SK Cancer Chemother Pharmacol; 1978; 1(1):15-24. PubMed ID: 155503 [No Abstract] [Full Text] [Related]
19. Development of a method for assessing the antitumor activity of chemotherapeutic agents using human tumor xenografts. Cobb LM; Mitchley BC Cancer Chemother Rep; 1974; 58(5 Pt 1):645-51. PubMed ID: 4609597 [No Abstract] [Full Text] [Related]
20. Melphalan: a potential new agent in the treatment of childhood rhabdomyosarcoma. Houghton JA; Cook RL; Lutz PJ; Houghton PJ Cancer Treat Rep; 1985 Jan; 69(1):91-6. PubMed ID: 3967262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]